Ototoxicity of <scp>Long‐Term α‐Difluoromethylornithine</scp> for Skin Cancer Prevention-Reference-Cited by-同舟云学术

Ototoxicity of Long‐Term α‐Difluoromethylornithine for Skin Cancer Prevention

Published:2022-05-27 Issue:3 Volume:133 Page:676-682
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Chow Cynthia L.¹,Havighurst Thomas²,Lozar Taja³^ORCID,Jones Todd D.⁴,Kim KyungMann²³,Bailey Howard H.³

Affiliation:

1. Consulting Audiology Associates, LLC Oak Park Illinois USA

2. Department of Biostatistics and Medical Informatics University of Wisconsin School of Medicine & Public Health Madison Wisconsin USA

3. Carbone Cancer Center, University of Wisconsin School of Medicine & Public Health Madison Wisconsin USA

4. Department of Surgery, Division of Otolaryngology‐Head and Neck Surgery University of Wisconsin School of Medicine & Public Health Madison Wisconsin USA

Funder

Division of Cancer Prevention, National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.30231

Reference37 articles.

1. Targeting ornithine decarboxylase by alpha‐Difluoromethylornithine inhibits tumor growth by impairing myeloid‐derived suppressor cells;Ye C;J Immunol,1950

2. Effect of polyamine metabolism inhibitors on Lewis lung carcinoma growth and metastasis;CAC SCO;Exp Oncol,2015

3. Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

4. Combination chemoprevention with diclofenac, calcipotriol and difluoromethylornithine inhibits development of non‐melanoma skin cancer in mice;Pommergaard HC;Anticancer Res,2013

5. Development of difluoromethylornithine (DFMO) as a chemoprevention agent;Meyskens FL;Clin Cancer Res,1999

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Clinical Research for Skin Cancer Chemoprevention;Cancers;2023-07-27